RT Journal Article
SR Electronic
T1 Detection of SARS-CoV-2 in the air from hospitals and closed rooms occupied by COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.30.20248890
DO 10.1101/2020.12.30.20248890
A1 Moharir, Shivranjani C
A1 Chandra, T. Sharath
A1 Goel, Arushi
A1 Thakur, Bhuwaneshwar
A1 Bhalla, Gurpreet Singh
A1 Kumar, Dinesh
A1 Naruka, Digvijay Singh
A1 Kumar, Ashwani
A1 Tuli, Amit
A1 Suravaram, Swathi
A1 Bingi, Thrilok Chander
A1 Srinivas, M
A1 Mesipogu, Rajarao
A1 Reddy, Krishna
A1 Khosla, Sanjeev
A1 Tallapaka, Karthik Bharadwaj
A1 Mishra, Rakesh K
YR 2021
UL http://medrxiv.org/content/early/2021/01/04/2020.12.30.20248890.abstract
AB To understand air transmission characteristics of SARS-CoV-2 and risks for health care personnel and visitors to hospitals, we analyzed air samples collected from various enclosures in hospitals at Hyderabad and Mohali and performed closed room experiments with COVID-19 positive individuals. We collected 64 air samples from COVID and non-COVID areas of various hospitals and 17 samples from closed rooms occupied by COVID patients. 4 samples from COVID care areas were positive for SARS-CoV-2 with no obvious predilection towards ICU/non-ICU areas in the hospital samples. In the closed room experiments, where one or more COVID-19 patients spent a short duration of time, one sample - collected immediately after the departure of three symptomatic patients from the room - was positive. Our results indicate that the chance of picking up SARS-CoV-2 in the air is directly related to a number of COVID positive cases in the room, their symptomatic status, and the duration of exposure and that the demarcation of hospital areas into COVID and non-COVID areas is a successful strategy to prevent cross infections. In neutral environmental conditions, the virus does not seem to spread farther away from the patients, especially if they are asymptomatic, giving an objective evidence for the effectiveness of physical distancing in curbing the spread of the epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCouncil of Scientific and Industrial Research, IndiaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Ethics Committee of CSIR-Centre for Cellular and Molecular Biology (IEC-83/2020)"All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data is available